Newborn screening for SMA in Southern Belgium
Approval was recently granted for a new treatment for spinal muscular atrophy (SMA). Given that the treatment is effective when administered early and the societal burden of SMA-related disability, the implementation of a newborn screening program is warranted. We describe the stepwise process that...
Autors principals: | Boemer, F, Caberg, J-H, Dideberg, V, Dardenne, D, Bours, V, Hiligsmann, M, Dangouloff, T, Servais, L |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Elsevier
2019
|
Ítems similars
-
(S)un (M)ay (A)rise on SMA: the hope of a region without spinal muscular atrophy
per: Boemer, F, et al.
Publicat: (2019) -
Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon-skipping therapy
per: Pablo Beckers, et al.
Publicat: (2021-02-01) -
Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium
per: François Boemer, et al.
Publicat: (2021-10-01) -
Feasibility and Acceptability of a Newborn Screening Program Using Targeted Next-Generation Sequencing in One Maternity Hospital in Southern Belgium
per: Dangouloff, T, et al.
Publicat: (2024) -
Feasibility and Acceptability of a Newborn Screening Program Using Targeted Next-Generation Sequencing in One Maternity Hospital in Southern Belgium
per: Tamara Dangouloff, et al.
Publicat: (2024-07-01)